On Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q2 2023 earnings per share (EPS) of -$0.87, up 99% year over year. Total Aprea Therapeutics earnings for the quarter were -$3.26 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$86.72.
As of Q3 2023, Aprea Therapeutics's earnings has grown year over year. Aprea Therapeutics's earnings in the past year totalled -$14.11 million.
What is APRE's earnings date?
Aprea Therapeutics's earnings date is Invalid Date. Add APRE to your watchlist to be reminded of APRE's next earnings announcement.
What was APRE's revenue last quarter?
On Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q2 2023 revenue of $249.69 thousand up Infinity% year over year. In the same quarter last year, Aprea Therapeutics's revenue was $0.00.
What was APRE's revenue growth in the past year?
As of Q3 2023, Aprea Therapeutics's revenue has grown null year over year. Aprea Therapeutics's revenue in the past year totalled $249.69 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.